Research Analysts Issue Forecasts for Acadia Healthcare Company, Inc.’s FY2018 Earnings (ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Cantor Fitzgerald issued their FY2018 earnings per share (EPS) estimates for Acadia Healthcare Company in a report issued on Friday. Cantor Fitzgerald analyst J. France expects that the company will post earnings of $2.85 per share for the year. Cantor Fitzgerald currently has a “Hold” rating and a $45.00 price target on the stock.

Acadia Healthcare Company (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. Acadia Healthcare Company had a return on equity of 8.89% and a net margin of 0.53%. The company had revenue of $679.20 million during the quarter, compared to the consensus estimate of $691.74 million. During the same quarter in the prior year, the firm earned $0.55 EPS. The company’s quarterly revenue was up 10.1% compared to the same quarter last year.

TRADEMARK VIOLATION NOTICE: “Research Analysts Issue Forecasts for Acadia Healthcare Company, Inc.’s FY2018 Earnings (ACHC)” was originally posted by Mideast Time and is the sole property of of Mideast Time. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.mideasttime.com/research-analysts-issue-forecasts-for-acadia-healthcare-company-inc-s-fy2018-earnings-achc/1811732.html.

A number of other analysts have also commented on ACHC. BidaskClub raised shares of Acadia Healthcare Company from a “sell” rating to a “hold” rating in a report on Saturday, June 10th. Mizuho reaffirmed a “buy” rating and set a $52.00 target price (up previously from $45.00) on shares of Acadia Healthcare Company in a report on Monday, February 27th. Zacks Investment Research lowered shares of Acadia Healthcare Company from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 1st. KeyCorp reaffirmed an “overweight” rating and set a $51.00 target price on shares of Acadia Healthcare Company in a report on Thursday, June 1st. Finally, TheStreet raised shares of Acadia Healthcare Company from a “d+” rating to a “c-” rating in a report on Friday, March 3rd. Five equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $57.82.

Shares of Acadia Healthcare Company (ACHC) traded up 0.71% during midday trading on Monday, hitting $48.37. The stock had a trading volume of 349,902 shares. The stock has a market cap of $4.25 billion, a PE ratio of 281.22 and a beta of 1.11. The stock has a 50-day moving average of $44.03 and a 200 day moving average of $41.09. Acadia Healthcare Company has a 52 week low of $32.54 and a 52 week high of $62.48.

Several institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Acadia Healthcare Company by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock worth $335,980,000 after buying an additional 59,735 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Acadia Healthcare Company by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares in the last quarter. BlackRock Inc. boosted its position in shares of Acadia Healthcare Company by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. Aristotle Capital Management LLC purchased a new position in shares of Acadia Healthcare Company during the first quarter worth $140,071,000. Finally, FMR LLC boosted its position in shares of Acadia Healthcare Company by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares in the last quarter.

In other news, COO Ronald Morgan Fincher sold 86,483 shares of Acadia Healthcare Company stock in a transaction on Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the transaction, the chief operating officer now directly owns 137,204 shares of the company’s stock, valued at $6,095,973.72. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Reeve B. Waud sold 724,694 shares of Acadia Healthcare Company stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $45.53, for a total transaction of $32,995,317.82. The disclosure for this sale can be found here. Over the last three months, insiders have sold 918,102 shares of company stock worth $41,781,109. Insiders own 11.10% of the company’s stock.

About Acadia Healthcare Company

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare Company (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.